Generic Name : Linagliptin Pronunciation : LIN-a-GLIP-tin Therapeutic Classification : Antidiabetics ICD Code : Y42.3
International- Tradjenta. Why it is prescribed (Indications) : This medication is a dipeptidyl peptidase-4 (DPP-4) inhibitor, prescribed for type 2 diabetes. It increases insulin secretion by pancreas. When it is not to be taken (Contraindications): Contraindicated in patients with history of high blood ketone levels, type 1 diabetes, and hypersensitivity.
Dosage & When it is to be taken : PO- The recommended dose is 5 mg once daily. How it should be taken : It comes as a tablet to take by mouth, with or without food. Warnings and Precautions :
* Caution should be exercised in patients with history of inflammation of the pancreas, using insulin, any allergy, who are taking other medications, during pregnancy and breastfeeding.
* Follow the diet and exercise program as directed by your physician.
* Monitor fasting blood glucose and hemoglobin A1c regularly while taking this medication. Side Effects :
Stuffy or runny nose, sore throat, inflammation of pancreas and low blood sugar.
* Avoid excess dosage. Storage Conditions :
Store it at room temperature (20 to 25°C).
Comment & Contribute
Ask an Expert